The year of approvals being 2022 was the last word
Post# of 148168
Things began to change in our overall appearance of our company team concept and little to no communication with shareholders. Good or bad it’s a tough reduction.
The excitement of this drug has fallen for me and we know that we have had a perfect gem of a drug all along. We just need to get his clinical hold off our back and our safety known to all that will listen and hear what we have to offer.
The most important item to me… other than a wonder drug that works… is the safety of Leronlimab.
If there is one thing I want Nader to have been truthful on… is the safety he preached of Leronlimab. I remember him saying they could overdose a rat even by giving the rat a 5,000mg injection and swelling the rat up with a huge dose of Leronlimab. Then the rat survived the huge dose. Please let this be true… We have a drug that has lots of potential for cancer and many other uses. Let Safety be it’s one attribute it is known for… cancer drugs are terrible in their side effects… let Leronlimab change this and be known as the safe drug with no real side effects. That would be a great thing for all that suffer with cancer treatment drugs.